Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection - Test2 - elhamkhani - TriplyDB

Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection

Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection

http://www.wikidata.org/entity/Q27486378

about

Drug-induced reactivation of apoptosis abrogates HIV-1 infection Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1 Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection Immunovirological parameters and cytokines in HIV infection Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections Functional contributions of carbohydrate on AIDS virus glycoprotein HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers Innate immune activation in primary HIV-1 infection.HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection.Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection Lack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic simian immunodeficiency virus infection CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques Multisite comparison of high-sensitivity multiplex cytokine assays.Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection A non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission Dual role of autophagy in HIV-1 replication and pathogenesis Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.Association of serum cytokines with oral HPV clearance.Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.Acute human immunodeficiency virus syndrome presenting with hemophagocytic lymphohistiocytosis.Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.Innate immune responses in primary HIV-1 infection.Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.

P2860

Q21090718-223FF09D-868F-43B1-90EF-7AFCB4A994D0 Q21133706-2E2E86F1-11BE-46C0-B013-F67C4FF2D5C0 Q24564396-BB845726-D541-4574-908B-FEA1E4D67424 Q26829264-36FC8A7A-05D3-4399-AADE-08816DDBE040 Q27488278-0411C6B2-DE95-4CDD-A0B8-141259ADC18F Q30397572-8F53BA3F-8379-4E3C-97C6-A3706B8E8593 Q33305012-51CBDE70-B02B-442A-BF60-61700D4E91BA Q33576664-803D3306-F940-4977-AA30-A5B2F2C3F7A1 Q33828507-A3926AFC-D226-488D-A155-1141A32D547C Q34155538-3E22F591-E928-4D86-9723-A45C592C88C8 Q34275430-5A913D92-E309-4F4E-AAEC-C1CCEB2FA516 Q34402041-9056F7B2-BE60-44BD-83D8-3A5A355EE827 Q34430248-C6F14C18-B916-4DD9-9146-3B21A4E509CE Q34441167-4584ED31-0B99-4203-A2A2-316A51BBC8A5 Q34500351-09F50F75-BABD-4E35-90E3-DCC9DDA5403D Q34594582-79BA16CD-05CE-4E23-8B9B-3C553C643C89 Q34633003-D9D286D0-F426-4BCA-936C-6A5518B0CC95 Q34707439-D860524B-2C31-46D0-A624-155D66B1B5D7 Q34764361-813FCBBA-35FA-44D2-AB4F-B1339A306063 Q35006056-3E5B7795-9ED8-43FF-A250-5FC391D9B5D6 Q35061216-5255259D-B1A2-4BD1-BCA9-5DD98A738686 Q35138516-0C8E913A-67C6-46D9-8AA6-B32F760F482F Q35138815-A156EAC6-F295-48B0-BC0B-58B566597111 Q35617066-80B48B8F-0F09-4104-89D3-CF21757C1C1C Q35780654-B9F20800-1263-488B-8BE1-0E5CB2E79562 Q35857580-DCEF3916-E242-45E0-8902-3C43B736F28F Q36026644-EB0D4264-BF42-4271-9302-0E4D08331587 Q36162133-2F854BCC-CB15-44B5-9667-C6877C887B86 Q36250357-ACE41579-E8EC-44B1-86C3-1CEDEA5A5B10 Q36363198-CD8557E2-9570-4974-AA9E-25F128ACF41E Q36421344-966059F1-7BA0-4990-92AD-61372427826F Q36445102-4DE10ABC-0C75-4278-8A9B-4B5DCC273D1A Q36736469-BB13D72B-CAF4-40AC-A9C4-A0D1ED98E4D5 Q36923830-94342EB6-1822-4FA6-90EA-B484416DA2D7 Q37039032-C5FD7424-8E29-4BD3-A3C4-9A226C4CBF57 Q37040999-A0FA0BE9-462A-4B9F-A6CC-1EF40E629A4F Q37194615-0EB5C2C1-90B9-4F1A-8DD9-33DDD68BABDD Q37227226-9908848C-2F6F-494F-BB56-CE6089D92E4B Q37262786-017E8122-747C-47A8-B143-4ACFD15A99F0 Q37271034-2059E3DE-A078-4A7C-A5DE-7490A98F3D42

P2860

Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection

http://www.wikidata.org/entity/Q27486378

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@ast

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@en

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@nl

type

label

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@ast

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@en

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@nl

prefLabel

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@ast

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@en

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@nl

P1433

Q27486378-FF4EB568-1771-4217-9DB5-5A0B71A39B56

P1476

Q27486378-22B88548-F22A-4890-BEC1-AF46DB998C4B

P2093

Q27486378-1504D767-33D5-4BB8-8456-39DC5F97F0ED

Q27486378-190F9208-FDF8-4A56-A107-D67D0B028BB5

Q27486378-373594B6-5077-4F57-ADD5-422B7A02DB9D

Q27486378-D3053A29-B75B-4E78-83D3-345DB61FE667

P2860

Q27486378-04351E72-83FD-4EA7-B334-0CEF4AE3BEC0

Q27486378-108F1C7D-8FB0-459B-BD04-B4EDA2EDD160

Q27486378-149D5CE5-92F3-4AFF-B4D3-ED2A977D1DB1

Q27486378-15B2BE8B-1DEC-4F98-8036-5E3F4BA4AE8F

Q27486378-185745D9-E903-46E5-8433-2E948FC90F0B

Q27486378-1E475786-CCFD-449A-823B-049A77C87CD0

Q27486378-21870276-05E9-4D7C-8FF0-9BAD9038382F

Q27486378-27B5F9DF-0FB8-4C47-9FF7-53D08EF8217E

Q27486378-2A56B603-FB7B-43A2-A937-C680D03901E7

Q27486378-2ED9BCE0-875D-4AD2-8BAC-C90B54E81F8F

P304

Q27486378-504012C9-1370-430E-9F20-B99920DD4861

P31

Q27486378-7F2137A5-A84C-430C-A70F-4FDE393D387A

P3181

Q27486378-5D68F360-937E-4D65-8950-2B35C70E967F

P356

Q27486378-99DA85A1-3887-43E5-9674-F609ADD20EFD

P433

Q27486378-AE23CA02-6855-4D63-AF31-EAE5787C3118

P478

Q27486378-31D8DCEA-F949-4B99-B203-53CF67ADE8EE

P50

Q27486378-06126818-CA10-4DD7-BBB9-8971E1E0033E

Q27486378-AA3E22C1-685C-4F39-ADE7-234203B5D086

P577

Q27486378-43FBEECC-9E4A-4FFB-AB98-F0DDBF2820B4

P5875

Q27486378-04A41474-59DB-4BFC-AAA5-F0850B4EE437

P698

Q27486378-7355A913-CEB7-42C6-9BB6-807DFEE0E070

P921

Q27486378-64D8D2E7-714D-493E-8A70-2647A86F5B68

P932

Q27486378-7D34B8B6-2437-41C7-9A05-B0F8CD3029EB

P3181

P356

AID.2006.22.757

P1433

AIDS Research and Human Retroviruses

P1476

Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection

@en

P2093

Brandee L Pappalardo

http://www.w3.org/2001/XMLSchema#string

Brian Custer

http://www.w3.org/2001/XMLSchema#string

Gerald Spotts

http://www.w3.org/2001/XMLSchema#string

Philip J Norris

http://www.w3.org/2001/XMLSchema#string

P2860

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS.

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

Cytokines and HIV-1: interactions and clinical implications.

P304

757-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1434877

http://www.w3.org/2001/XMLSchema#string

P356

10.1089/AID.2006.22.757

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Frederick M. Hecht

Michael P. Busch

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6876430

http://www.w3.org/2001/XMLSchema#string

P698

16910831

http://www.w3.org/2001/XMLSchema#string

P921

P932

2431151

http://www.w3.org/2001/XMLSchema#string